These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 6299565)
1. Relationship of benign papillomas to cancer induction in mouse skin. Burns FJ; Albert RE Cancer Detect Prev; 1981; 4(1-4):99-107. PubMed ID: 6299565 [TBL] [Abstract][Full Text] [Related]
2. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type. Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681 [TBL] [Abstract][Full Text] [Related]
3. Evidence for a new model of tumor progression from carcinogenesis and tumor promotion studies with 7-bromomethylbenz[a]anthracene. Scribner JD; Scribner NK; McKnight B; Mottet NK Cancer Res; 1983 May; 43(5):2034-41. PubMed ID: 6403231 [TBL] [Abstract][Full Text] [Related]
4. NTP Initiation/Promotion Study of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in Swiss (CD-1(R)) Mice (Mouse Skin Study). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1995 May; 444():1-136. PubMed ID: 12595919 [TBL] [Abstract][Full Text] [Related]
5. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols. Iversen OH APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481 [TBL] [Abstract][Full Text] [Related]
6. Only a subset of 12-O-tetradecanoylphorbol-13-acetate-promoted mouse skin papillomas are promotable by benzoyl peroxide. Mancuso M; Pazzaglia S; Tanori M; Rebessi S; Di Majo V; Covelli V; Saran A Mutat Res; 2004 Apr; 548(1-2):35-45. PubMed ID: 15063134 [TBL] [Abstract][Full Text] [Related]
7. The reverse experiment in two-stage skin carcinogenesis. It cannot be genuinely performed, but when approximated, it is not innocuous. Iversen OH APMIS Suppl; 1993; 34():1-96. PubMed ID: 8251199 [TBL] [Abstract][Full Text] [Related]
8. Skin tumor-initiating activities of the twelve isomeric phenols of benzo(a)pyrene. Slaga TJ; Bracken WM; Dresner S; Levin W; Yagi H; Jerina DM; Conney AH Cancer Res; 1978 Mar; 38(3):678-81. PubMed ID: 626971 [TBL] [Abstract][Full Text] [Related]
9. Regression kinetics of mouse skin papillomas. Burns FJ; Vanderlaan M; Sivak A; Albert RE Cancer Res; 1976 Apr; 36(4):1422-7. PubMed ID: 816464 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone. Verma AK; Garcia CT; Ashendel CL; Boutwell RK Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052 [TBL] [Abstract][Full Text] [Related]
11. Sequential studies of skin tumorigenesis in phosphoglycerate kinase mosaic mice: effect of resumption of promotion on regressed papillomas. Reddy AL; Caldwell M; Fialkow PJ Cancer Res; 1987 Apr; 47(7):1947-51. PubMed ID: 3102053 [TBL] [Abstract][Full Text] [Related]
12. Dose-time response in mouse skin tumor induction by 7, 12-dimethylbenz[a]anthracene and 12-O-tetradecanoyl-phorbol-13-acetate. Lutz WK; Beland PE; Candrian R; Fekete T; Fischer WH Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 1):44-8. PubMed ID: 8628919 [TBL] [Abstract][Full Text] [Related]
13. Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin. Slaga TJ; Gleason GL; DiGiovanni J; Sukumaran KB; Harvey RG Cancer Res; 1979 Jun; 39(6 Pt 1):1934-6. PubMed ID: 109189 [TBL] [Abstract][Full Text] [Related]
14. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin. Owens DM; Spalding JW; Tennant RW; Smart RC Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738 [TBL] [Abstract][Full Text] [Related]
15. Tumor-initiating activity and carcinogenicity of dibenzo[a,l]pyrene versus 7,12-dimethylbenz[a]anthracene and benzo[a]pyrene at low doses in mouse skin. Higginbotham S; RamaKrishna NV; Johansson SL; Rogan EG; Cavalieri EL Carcinogenesis; 1993 May; 14(5):875-8. PubMed ID: 8504480 [TBL] [Abstract][Full Text] [Related]
16. Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn mice. Buening MK; Levin W; Wood AW; Chang RL; Lehr RE; Taylor CW; Yagi H; Jerina DM; Conney AH Cancer Res; 1980 Feb; 40(2):203-6. PubMed ID: 7356502 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Zhou HM; Bolon I; Nichols A; Wohlwend A; Vassalli JD Cancer Res; 2001 Feb; 61(3):970-6. PubMed ID: 11221892 [TBL] [Abstract][Full Text] [Related]
18. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13-acetate-caused skin tumor promotion in 7,12-dimethylbenz[a]anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Meeran SM; Vaid M; Punathil T; Katiyar SK Carcinogenesis; 2009 Mar; 30(3):520-8. PubMed ID: 19158151 [TBL] [Abstract][Full Text] [Related]
19. Differential effects of retinoic acid and 7,8-benzoflavone on the induction of mouse skin tumors by the complete carcinogenesis process and by the initiation-promotion regimen. Verma AK; Conrad EA; Boutwell RK Cancer Res; 1982 Sep; 42(9):3519-25. PubMed ID: 6286109 [No Abstract] [Full Text] [Related]
20. Protection against malignant conversion of chemically induced benign skin papillomas to squamous cell carcinomas in SENCAR mice by a polyphenolic fraction isolated from green tea. Katiyar SK; Agarwal R; Mukhtar H Cancer Res; 1993 Nov; 53(22):5409-12. PubMed ID: 8221679 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]